Uncovering targets and molecular pathways for personalizing treatment in epilepsy.

Key Points

• The aim is to identify specific molecular targets and pathways to enhance treatment personalization in epilepsy.
• Explores current and future small molecule and gene therapies.
• Focuses on allele-specific versus allele-nonspecific therapeutic designs.
• Considers the implications of pathological variants in treatment efficacy.
• Highlights potential benefits of allele-specific gene therapy for certain patients.
• Identifies that not all pathological variants will benefit from existing therapies.
• Suggests personalized approaches may improve treatment outcomes.